Goldman Sachs’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $32K | Sell |
|
|||||
|
2022
Q2 | $87K | Buy |
|
|||||
|
2022
Q1 | $155K | Sell |
|
|||||
|
2021
Q4 | $232K | Sell |
|
|||||
|
2021
Q3 | $378K | Sell |
|
|||||
|
2021
Q2 | $525K | Buy |
|
|||||
|
2021
Q1 | $770K | Buy |
|
|||||
|
2020
Q4 | $625K | Buy |
|
|||||
|
2020
Q3 | $658K | Buy |
|
|||||
|
2020
Q2 | $122K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $39K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $105K | Sell |
|
|||||
|
2015
Q2 | $146K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $779K | Sell |
|
|||||
|
2014
Q3 | $1.04M | Sell |
|
|||||
|
2014
Q2 | $2.04M | Buy |
|
|||||
|
2014
Q1 | $1.84M | Sell |
|
|||||
|
2013
Q4 | $1.07M | Sell |
|
|||||
|
2013
Q3 | $1.21M | Buy |
|